LONDON, March 10, 2016 /PRNewswire/ -- Neuromodulation Technologies - A Strategic Perspective (TechVision) : Evaluating Technology's Role in Driving Strategic Transformation within Global Neuromodulation Industry
Over the past decade, global industry leaders offering neuromodulation technologies have been largely successful in implementing large scale value stream transformation programs in setting a mature cost-to-serve model. However, understanding the gaps between OEM initiatives in delivering value to care payers and payer demands have been limited. This research service offers a strategic perspective on the industry, analyzing the gaps between technology push-pull factors that are poised to enable OEMs sustain both volume growth and margin. This research also examines how OEMs can shift from a value-to-cost model to a value-to-serve business model, which plays a lead role in delivering personalized value to healthcare payers and care providers.
There is a significant demand for research on cardiovascular disorders, where existing participants in the market invest significant resources focusing on generating sufficient clinical evidence for conditions such as arrhythmia, ischemia and heart failure.
The recent focus of top OEMs on single-source suppliers helps in improving operational efficiency, and balancing quality, delivery, and cost. However, translation of cost-reduction efforts to payers and driving reimbursement is critical for top-line growth.
Findings of the benchmarking clearly suggest that there is a shift toward minimally-invasive and connected health technologies that enable patients to take therapy at the convenience of the physicians office or at home. Percutaneous stimulation technologies are a step in this direction.
To sustain profitable growth, OEMs must align strategic intent towards building a value-driven business model that is well differentiated in its offerings to mature markets, where cost efficiencies are transferred across the value stream.
Our analysis evaluates the real-world examples, and emerging business models where customer value is driven by early adoption and successful integration of social, mobile, analytics and networking, which is key to driving efficiency across the value stream.
Acquisitions enable OEMs to drive market growth and the forward integration moves of existing single-source suppliers could pose a threat to the profitability of OEMs.
Entry of minimal/non-invasive technologies with strong IP, regulatory approvals (CE/TGA) and strong clinical data for chronic lifestyle disorders would drive further consolidation within the market by acquisitions by OEMs, giving exit to VC/PE firms.
While OEMs continue to gain ground in establishing safety/efficacy for existing products in mature markets, their VC counterparts continue to invest early in technologies, enabling the launch of new products/services for existing markets.
OEMs have been successful in implementing large-scale value stream transformation programs to single-source suppliers; this is expected to reduce the overall cost of activities across the value chain, with a mature cost-to-serve model.
Download the full report: https://www.reportbuyer.com/product/3691051/
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
For more information:
Research Advisor at Reportbuyer.com
Tel: +44 208 816 85 48